- Home
- SGMO vs CGO Comparison
SGMO vs CGO Comparison
Compare SGMO & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- CGO
- Stock Information
- Founded
- SGMO 1995
- CGO 2004
- Country
- SGMO United States
- CGO United States
- Employees
- SGMO N/A
- CGO N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- CGO Investment Managers
- Sector
- SGMO Health Care
- CGO Finance
- Exchange
- SGMO Nasdaq
- CGO Nasdaq
- Market Cap
- SGMO 122.8M
- CGO 114.5M
- IPO Year
- SGMO 2000
- CGO N/A
- Fundamental
- Price
- SGMO $0.45
- CGO $11.51
- Analyst Decision
- SGMO Buy
- CGO
- Analyst Count
- SGMO 7
- CGO 0
- Target Price
- SGMO $4.71
- CGO N/A
- AVG Volume (30 Days)
- SGMO 4.6M
- CGO 34.7K
- Earning Date
- SGMO 11-06-2025
- CGO 01-01-0001
- Dividend Yield
- SGMO N/A
- CGO 9.25%
- EPS Growth
- SGMO N/A
- CGO N/A
- EPS
- SGMO N/A
- CGO N/A
- Revenue
- SGMO $32,875,000.00
- CGO N/A
- Revenue This Year
- SGMO $28.47
- CGO N/A
- Revenue Next Year
- SGMO N/A
- CGO N/A
- P/E Ratio
- SGMO N/A
- CGO N/A
- Revenue Growth
- SGMO N/A
- CGO N/A
- 52 Week Low
- SGMO $0.41
- CGO $7.90
- 52 Week High
- SGMO $2.84
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- SGMO 29.91
- CGO 34.85
- Support Level
- SGMO $0.42
- CGO $11.48
- Resistance Level
- SGMO $0.53
- CGO $12.15
- Average True Range (ATR)
- SGMO 0.04
- CGO 0.18
- MACD
- SGMO -0.01
- CGO -0.03
- Stochastic Oscillator
- SGMO 11.96
- CGO 13.37
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.